---
document_datetime: 2024-09-20 16:39:42
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/eylea-epar-all-authorised-presentations_en.pdf
document_name: eylea-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9435873
conversion_datetime: 2025-12-26 09:28:33.50032
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength    | Pharmaceutical form    | Route of administration   | Immediate packaging        | Content (concentration)   | Pack size                |
|------------------|-------------------|-------------|------------------------|---------------------------|----------------------------|---------------------------|--------------------------|
| EU/1/12/797/001  | Eylea             | 40 mg/ml    | Solution for injection | Intravitreal use          | pre-filled syringe (glass) | 0.09 mL                   | 1 pre-filled syringe     |
| EU/1/12/797/002  | Eylea             | 40 mg/ml    | Solution for injection | Intravitreal use          | vial (glass)               | 0.1 mL                    | 1 vial + 1 filter needle |
| EU/1/12/797/003  | Eylea             | 114.3 mg/ml | Solution for injection | Intravitreal use          | vial (glass)               | 0.263 mL                  | 1 vial + 1 filter needle |
| EU/1/12/797/004  | Eylea             | 114.3 mg/ml | Solution for injection | Intravitreal use          | pre-filled syringe (glass) | 0.184 mL                  | 1 pre-filled syringe     |